EFG Hermes Advises on the Signing of Landmark $190 Million Investment in Alameda Healthcare by DPI

EFG Hermes, an EFG Holding company and the leading investment bank in the Middle East and North Africa, announced today that its investment banking division acted as the Sole M&A Financial Advisor on the signing of binding agreements for a $190 million minority stake investment in Alameda Healthcare (“Alameda”), Egypt’s leading private healthcare group, by Development Partners International (“DPI”), in partnership with a consortium of leading institutional investors and prominent development finance institutions.

Dr. Fahad Khater, Chairman of Alameda, will remain the group’s majority shareholder following the transaction. The transaction, which is primarily a capital increase, is subject to customary regulatory approvals and is expected to close in Q3 2025.

This cornerstone foreign direct investment, currently in its final stages, represents the largest of its kind in Egypt’s healthcare sector, reinforcing investor confidence in backing resilient and fast-growing businesses across the country. The transaction, primarily being a capital increase in Alameda, will result in foreign currency proceeds entering Egypt’s local banking system and support the company’s growth in Egypt and GCC markets.

Commenting on the transaction, Maged El Ayouti, Co-Head of Investment Banking at EFG Hermes, said: “We are honored to have led this landmark transaction as the Sole M&A Financial Advisor, attracting $190 million for a significant minority stake in one of the leading and fast-growing healthcare platforms in the region. The transaction marks a proud moment for EFG Hermes as we support a national healthcare champion led by Dr Fahad Khater in executing a transformative capital raise that will enable the platform’s journey to grow and scale across the region. This transaction underscores our capabilities to deliver on our advisory to our clients on landmark M&A transactions across Egypt and the broader region, as it follows a series of M&A deals that we have advised on in the last 18 months with an aggregate value exceeding $2.5 billion”.

Since the beginning of the year, EFG Hermes has advised on 4 M&A transactions, 7 DCM transactions, and 7 ECM transactions across the region, including landmark transactions in Egypt, UAE, Saudi Arabia, and Oman, underscoring its leadership in regional markets.

This investment aims to consolidate Alameda’s position as a national healthcare leader while enabling its strategic expansion across Egypt and the wider region. The capital increase will allow the Group to deliver and invest in expanding its hospital operations and clinical capacity, particularly in Egypt and regionally in key markets such as KSA, UAE, and other GCC markets.